Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Chromatography Column Cleaning Before Reuse – V 2.0

Posted on By


Biosimilars: SOP for Chromatography Column Cleaning Before Reuse – V 2.0


Standard Operating Procedure for Chromatography Column Cleaning Before Reuse in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/135/2025
Supersedes SOP/BS/135/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To establish a validated procedure for cleaning chromatography columns used in biosimilar purification prior to reuse, in order to remove residual product, prevent cross-contamination, and maintain resin performance as per GMP and manufacturer’s guidelines.

2. Scope

This SOP applies to Protein A, ion exchange, hydrophobic interaction, and size exclusion chromatography columns used in the downstream processing (DSP) of biosimilar products in GMP manufacturing areas.

3. Responsibilities

  • DSP Operators: Execute column cleaning procedures and log cleaning steps.
  • Engineering: Maintain cleaning skid/systems and verify flowrates, temperature, and pressure parameters.
  • QA: Review cleaning logs and verify cleaning validation or routine status before next column use.

4. Accountability

The Head of Manufacturing is accountable for ensuring chromatography column cleaning procedures are performed as per validated protocols and that logs are completed and approved before reuse.

5. Procedure

5.1 Pre-Cleaning Inspection

  1. Confirm cleaning is required post purification run.
  2. Verify the cleaning method (CIP/manual) as per the column type and resin specification.
  3. Check column ID, resin type, batch number, and previous use log (Annexure-1).

5.2 Column Cleaning Steps

  1. Attach column to cleaning skid or validated cleaning system.
  2. Flush with WFI or buffer until UV baseline stabilizes (typically 5–10 CV).
  3. Use appropriate cleaning agents depending on resin type:
    • Protein A: 0.5 M NaOH, hold for 30 min contact time
    • IEX: 1 M NaCl followed by 0.5 M NaOH
    • SEC: 0.1 M NaOH or 20% ethanol (for microbial control)
  4. Flush column with WFI until pH and conductivity reach neutral range (pH 6.0–8.0).
  5. Record volumes, contact times, and final UV/conductivity readings in Annexure-2.

5.3 Sanitization and Storage

  1. For long-term storage, sanitize with 20% ethanol or 0.1 M NaOH as per resin compatibility.
  2. Seal column ends and affix storage label with:
    • Last cleaning date
    • Next due date
    • Resin lifetime usage (number of cycles)

5.4 Cleaning Validation/Verification

  1. Initial 3 cleaning cycles post-purchase shall be validated using:
    • TOC (Total Organic Carbon)
    • Protein assay (BCA or Lowry)
    • Microbial swabs
  2. Routine verification can be performed every 5 cycles and documented in Annexure-3.

5.5 Documentation

  1. Ensure all cleaning records are updated in the Chromatography Column Cleaning Log (Annexure-4).
  2. QA review and approval must be completed before next batch allocation.

6. Abbreviations

  • CIP: Clean-In-Place
  • CV: Column Volume
  • DSP: Downstream Processing
  • QA: Quality Assurance

7. Documents

  1. Column Usage Log – Annexure-1
  2. Column Cleaning Record – Annexure-2
  3. Cleaning Validation Report – Annexure-3
  4. Column Cleaning Master Log – Annexure-4

8. References

  • Resin Manufacturer Cleaning Instructions
  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • EU GMP Annex 15 – Qualification and Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Column Usage Log

Column ID Resin Batch Used Cycle No. Last Cleaning Date
COL-001 Protein A BS-DSP-042 18 01/05/2025

Annexure-2: Column Cleaning Record

Date Cleaning Agent Volume (L) Contact Time (min) Rinse pH Conductivity
04/05/2025 0.5 M NaOH 10 30 7.2 5.1 µS/cm

Annexure-3: Cleaning Validation Report

Date TOC Protein Microbial Status
04/05/2025 Pass Pass Pass Validated

Annexure-4: Column Cleaning Master Log

Column ID Date Cycle No. Performed By QA Reviewed
COL-001 04/05/2025 19 Ajay Verma Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added sanitization step and validation frequency Process Enhancement
See also  Biosimilars: SOP for Media Hold Time Validation in Bioreactor Operations - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Label Printing and Verification for Injectable Products – V 2.0
Next Post: Aerosol: SOP for Monitoring Spray Consistency in Batch Production – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version